Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Sircar, Geetabali, Goswami, Rudra Prosad, Sircar, Dipankar, Ghosh, Alakendu, Ghosh, ParasarLanguage:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/key213
Date:
July, 2018
File:
PDF, 377 KB
english, 2018